See our latest analysis for Zeon.
Momentum has been building for Zeon, as the company’s 15.1% total shareholder return over the last year stands out in contrast to steady sector performance. With a 9.6% share price gain year-to-date, investors appear to be taking a more optimistic view, particularly as the stock rebounds from a slow start to the quarter.
If Zeon's recent gains have you scanning for the next opportunity, this could be a timely moment to discover fast growing stocks with high insider ownership
With Zeon’s shares trending upward and valuation metrics showing a sizable discount to analyst price targets, the key question is whether the stock remains undervalued or if the market is already pricing in future growth prospects.
Price-to-Earnings of 8.6x: Is it justified?
Zeon’s shares are trading at a price-to-earnings (P/E) ratio of 8.6x, which positions the stock attractively below both its industry peers and the broader market. This stands out especially after a notable rally in the share price.
The price-to-earnings ratio compares Zeon’s current share price to its earnings per share, providing a snapshot of how the market is valuing the company’s ability to generate profits. In the chemicals sector, the P/E is a widely used indicator for assessing whether future earnings potential is fully recognized by investors.
Zeon’s P/E of 8.6x is not only below the JP Chemicals industry average of 13x, but also undercuts the peer group’s average of 20.2x. Compared to the estimated Fair Price-to-Earnings Ratio of 12.7x, the current multiple further highlights a significant discount and suggests there may be upward valuation potential as market perceptions evolve.
Explore the SWS fair ratio for Zeon
Result: Price-to-Earnings of 8.6x (UNDERVALUED)
However, recent declines in quarterly revenue growth and net income could signal ongoing challenges that may limit further gains in Zeon’s share price.
Find out about the key risks to this Zeon narrative.
Another View: The SWS DCF Model’s Perspective
While Zeon’s price-to-earnings ratio signals the stock might be undervalued, our SWS DCF model offers a different angle. This approach, which estimates a company’s worth by projecting future cash flows, suggests Zeon's fair value could be much higher than its current price. This raises the question of whether there is a deep discount or if the model overlooks risks recognized by the market.
Look into how the SWS DCF model arrives at its fair value.
Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Zeon for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 876 undervalued stocks based on their cash flows. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.
Build Your Own Zeon Narrative
If you want to dig deeper or come to your own conclusions, you can build and share your own narrative in just a few minutes. Do it your way.
A great starting point for your Zeon research is our analysis highlighting 4 key rewards and 2 important warning signs that could impact your investment decision.
Looking for more investment ideas?
Make sure you do not miss the movers and shakers outside of Zeon. Tap into fresh opportunities tailored to your goals with these hand-picked stock ideas from Simply Wall Street:
- Unlock steady income streams by reviewing these 16 dividend stocks with yields > 3%, featuring companies delivering attractive yields above 3% for income-focused investors.
- Capture game-changing innovations by checking out these 25 AI penny stocks, where artificial intelligence is fueling growth across industries.
- Seize potential value by searching through these 876 undervalued stocks based on cash flows and spot businesses trading at compelling prices based on their future cash flows.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Valuation is complex, but we're here to simplify it.
Discover if Zeon might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com